Long COVID most prevalent in the most seriously ill
A collaborative study involving researchers from Karolinska Institutet has charted the prevalence of severe physical symptom burden amongst Scandinavians for up to two years after a SARS-CoV-2 infection.
Breakthrough for ‘neglected’ rheumatic condition
Scientists have found success in treating a ‘neglected’ inflammatory condition, polymyalgia rheumatica, with a drug that could provide an alternative to steroids for patients.
New ‘Subway Map’ of Lyme Disease Pathways Identifies Potential New Treatment Targets
The model, created by Tufts University researchers, showed that two existing drugs demonstrate potential for more selective therapeutic options.
Genetics influence the risk of blood clots in oral contraceptive users
Women with a high genetic predisposition for blood clots are six times more likely to develop a blood clot during the first two years of using contraceptive pills…
Unlocking the secrets of cell behaviour on soft substrates: A paradigm shift in mechanobiology
A research group from the University of Turku and Turku Bioscience Centre together with Misvik Biology Ltd in Finland have developed a new method for studying how cancer…